Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


5th Ocular Diseases Drug Discovery

21 Mar 2013 - 22 Mar 2013 - San Francisco, USA



Bookmark and Share


The Ocular Diseases & Drug Development Conference taking place on March 21-22, 2013 in San Francisco, CA is now in its fifth year. As chairperson and moderator, I look forward to attending this conference. It continues to offer presentations on novel and innovative therapeutics in ocular drug development and discovery. This year we are fortunate to have Dr. Samir Patel, CEO and President of Ophthotech, as our keynote speaker. A leader in the field, Dr. Patel, a trained retina specialist, will present data from his recent clinical studies on a new and adjunct treatment for wet AMD, Fovista. We have two panels at this year's conference: 1) a safety regulatory panel with experts in the field being moderated by Dr. Ken Mandell and 2) a VC/ BD panel being moderated by Dr. Emmett Cunningham. This forum allows for excellent networking, the exchange of ideas, and sharing of challenges; all with a united common goal of bringing new and innovative treatments to patients in the area of ophthalmology.

The conference features the following topics:

Session: Novel Targets, Developments and Technologies

Session: Novel Drug Delivery Methods to the Anterior and Posterior Segments

Session: Clinical Development Advances & Updates 

Session: Safety Assessment and Regulatory Landscape in Ocular Drug Development

Session: Short Presentations

Panel Discussion: BD, Investments and Potential for Collaborations

Panel Discussion: Safety and Regulatory in Ocular Development



Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!